MPX International Corporation is a Canadian cannabis company focused on developing and operating cannabis assets around the world, with an emphasis on cultivation, manufacturing and product marketing.
Lexaria Bioscience Corp. develops and out-licenses its disruptive and cost-effective DehydraTECH™ technology, promoting healthier administration methods and lower overall dosing.
The company focuses on developing leading-edge options for curative and preventative therapies for diabetes and obesity, pain management, neurological disorders and cancer.
XORTX is a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease.
Click here to see current stock offerings from Richmond Club Index companies
Click here to subscribe to Greg’s Stock Picks Newsletter
Click here to subscribe to the Richmond Club Youtube channel to be notified of new company interviews and presentations.
Since small-cap companies are volatile, Greg Beckett recommends the following:
- Buy a portfolio of at least five Richmond Club companies
- Hold them for at least one year and
- Consult your Investment Advisor before buying any stock